Field evaluation of an exoantigen-containing Babesia vaccine in Venezuela
Mem. Inst. Oswaldo Cruz
;
87(supl.3): 283-8, 1992. tab, ilus
Artículo
en Inglés
| LILACS
| ID: lil-121117
ABSTRACT
Bovine babesiosis is endemic in Venezuela, causing significant losses in highly susceptible imported cattle. Current immunoprphylatic methods include the less desirable use of live parasites. Inactivated vaccines derived from exoantigen-containing supernatant fluids of in vitro Babesia bovis and B. bigemina cultures have been developed and constitute a major improvement in vaccine safety, stability and ease of handling. Vaccination trials conducted under field conditions provide the final evaluation of a culture-derived B. bovis-B. bigemina vaccine. During a 5-year period, approximately 8,000 cattle were vaccinated and 16 clinical trials carried out in. 7 states of Venezuela Clinical, serologic and parasitologic data were collected monthly from 10% of the animals over a 2-year period. Data were also collected from a similar number of nonvaccinated control cattle. Analysis of results from these trials demonstrated a reduction in the incidence of clinical disease among vaccinated animals and complete protection against mortality among vaccinated and nonvaccinated cattle. Use of this inactivated vaccine offers the best combination od safety, potency and efficacy for thew immunoprophylatic control of bovine babesiosis
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Babesia
/
Babesiosis
/
Vacunas
Límite:
Animales
País/Región como asunto:
America del Sur
/
Venezuela
Idioma:
Inglés
Revista:
Mem. Inst. Oswaldo Cruz
Asunto de la revista:
Medicina Tropical
/
Parasitología
Año:
1992
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS